This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Allison, P. L Articles by Zwischenberger, J. B Search for Related Content PubMed PubMed Citation Articles by Allison, P. L Articles by Zwischenberger, J. B Social Bookmarking                         What's this?

Devices and monitoring during neonatal ECMO: su rvey results

Extracorporeal Membrane Oxygenation Program, University of Texas Medical Branch, Galveston, Texas

Mark Kurusz

Extracorporeal Membrane Oxygenation Program, University of Texas Medical Branch, Galveston, Texas

Donna F Graves

Extracorporeal Membrane Oxygenation Program, University of Texas Medical Branch, Galveston, Texas

Joseph B Zwischenberger

Extracorporeal Membrane Oxygenation Program, University of Texas Medical Branch, Galveston, Texas

A survey of active ECMO centres regarding neonatal ECMO equipment and personnel was obtained by telephone interview in late summer 1989. Forty-seven of the centres in the USA listed in the Ann Arbor ELSO (Extracorporeal Life Support Organization) Registry at the time (>90%) were contacted and all participated. Nearly all use a roller pump, while less than 5% use a centrifugal pump. All programmes use a SciMed membrane oxygenator and 91 % a SciMed heat exchanger. Heat exchanger water sources include the Gaymar T-pump (42%), Seabrook (25%) and Cincinnati Sub-Zero (23%) units. Eighty-seven per cent use a bladder box servo-regulated to the roller pump; these are most often custom-made (69%) but 13% of programmes use a commercially available (Seabrook) bladder box. Ten per cent use a pressure-regulated roller pump rather than a conventional (displacement) bladder box to detect decreases in venous return. Nearly 80% monitor circuit line pressures between the pump and patient. Seventeen per cent use an air bubble detector on the arterial side of the circuit. Only 10% use an arterial bubble trap and 6% an arterial line filter. Seventy-five per cent do not monitor gas line pressures into the membrane lung, but one-third do use a gas line pop-off valve to prevent elevated gas phase pressures. Seventy per cent reported use of continuous in-line measurement of mixed venous oxygen saturation; no programme reported any blood chemistries being monitored in line. About 50% use an oxygen analyser for the oxygenator sweep gas and one-fifth use a blood flow meter. Fifty per cent monitor blood temperature in the circuit. Seventy-two per cent monitor activated clotting times with a Hemochron device, 21 % with a Trimed ACTester and 4% with a Hemotec ACT. The background of ECMO specialists was primarily registered nurses, but many programmes also use respiratory therapists and perfusionists. These data may provide guidance for new programmes and suggest technological improvements.

Perfusion, Vol. 5, No. 3, 193-201 (1990)
DOI: 10.1177/026765919000500305


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?